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Accepted 22 July 2010The most common pathogen isolated from cases of puer-
peral mastitis is Staphylococcus aureus, representing 35e50%
of isolates and being associated with a higher risk of abscess
formation [1]. Recently, oxacillin-resistant S aureus (ORSA)
has been reported to be the main pathogen in puerperal
mastitis [2]. In the study of all cases of postpartum mastitis
that were culture positive for S aureus, 44% isolates were
oxacillin resistant [2]. Traditionally, a breast abscess was
drained with surgical incision under general anesthesia fol-
lowed by regular wet dressing and secondary wound closure
[3]. However, the considerable pain and hospitalization often
leads to early weaning from breastfeeding. A less invasive
alternative is ultrasound-guided needle aspiration using local
anesthesia [4]. Here, we present a case of ORSA puerperal
mastitis with abscess formation successfully treated with
aspiration and antimicrobial therapy.
A 27-year-old woman had her first baby born via a vaginal
delivery, and she expressed milk with a breast pump for
feeding. Five weeks after delivery, a tender mass was found in
the left upper quadrant of her right breast; and the skin became
red and warm. Amoxicillin-clavulanate was prescribed by her
obstetrician as empiric treatment. Because the local heat and
redness progressed in the following 2 days, she came to our
clinic for a second opinion.
The redness was measured as being 15 cm wide. Breast
sonar revealed two breast abscess loci. The shallower one was
about 3 cm wide but the deeper one was beyond the limitations
of our linear ultrasound probe (20 MHz; Toshiba, Japan).
Under the guidance of ultrasound, 3 mL of pus was aspirated
from the shallower abscess. The deeper abscess was difficult to
be approached (Fig. 1). The empiric antimicrobial agent was
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the pus yielded growth of ORSA. The culture of expressed
milk showed mixed growth of ORSA and oxacillin-resistant
coagulase-negative staphylococcus. By the disc diffusion
method, both strains were susceptible to trimethoprim-
sulfamethoxazole, fusidic acid, teicoplanin, and vancomycin.
Trimethoprim-sulfamethoxazole was maintained according to
the susceptibility test. Breastfeeding continued after confirm-
ing her baby was not suffering from glucose-6-phosphate
dehydrogenase (G6PD) deficiency by newborn blood
screening at the birth of the baby.
At her follow-up visit 1 week later, the redness and local
heat of the right breast had decreased and the tender area
shrunk. The shallower abscess had disappeared (Fig. 2) and
the width of the deeper abscess remained about 4 cm (Fig. 3).
The deeper abscess was aspirated and the culture also showed
growth of ORSA.
At her follow-up visit 2 weeks later, the skin redness had
disappeared and only a 1 cm nontender anechoic area was
found by ultrasound on the previous lesion. The fluid content
of the anechoic area was aspirated under guidance of ultra-
sound. Minimal blood-tinged yellowish fluid was aspirated
and culture did not yield growth of bacteria. No abscesses or
skin change were detected at the 4-week follow-up visit.
Puerperal mastitis is not an uncommon complication
among breastfeeding women. Only 10e15% of patients with
puerperal mastitis require medical intervention, such as anti-
microbial therapy, and about 10% of puerperal mastitis cases
progress to abscess formation.
In the guideline provided by World Health Organization
(WHO) of treating puerperal mastitis, the main principles of
treatment of mastitis include supportive counseling, antibiotic
therapy, symptomatic treatment, and effective milk removal.
Besides, abscesses must be drained to improve outcome [5]. In
WHO guideline, breastfeeding should be continued by
keeping baby with the mother both before and after surgery,cs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Breast ultrasound: An abscess in width of 2.76 cm (big arrow) and
another deeper abscess was beyond the detection of the ultrasound probe
(small arrow).
Fig. 3. Breast ultrasound: The deeper abscess shrunk 1 week after needle
aspiration (arrow).
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side as far as the pain of the wound allows [5]. In the present
case, the deeper abscess that could not be approached also
showed a response to the effective antimicrobial agent.
Adequate antimicrobial therapy is therefore important for
patients with abscesses that cannot be drained completely.
Compared with traditional incision and drainage, ultrasound-
guided needle aspiration is less invasive and with better
cosmetic outcomes. In addition, breastfeeding is considerably
easier for a patient without a retained open wound.
In puerperal breast abscesses, S aureus is the most frequent
pathogen [1]. Penicillinase-stable penicillins, such as oxacillin,
have become the mainstay of treatment of staphylococcal
infections [6]. According to the recommendations of the
WHO, empiric therapy often starts with dicloxacillin, cepha-
lexin, amoxicillin, or erythromycin [5].
Because of cross-resistance, ORSA is often resistant to all
b-lactam antibiotics, such as cephalosporins; penicillins,
including amoxicillin; and even in combination with
a b-lactamase inhibitor [6]. Among S aureus isolates fromFig. 2. Breast ultrasound: The shallower abscess was measured at a width of
1.2 cm 1 week after needle aspiration (arrow).patients with soft tissue infections, the prevalence of ORSA has
been reported to be around 60% and there is little difference in
rates of oxacillin resistance between community and hospital
strains [7,8]. In a study on patients with puerperal mastitis
requiring hospitalization, 59% of cultures from cases with
breast abscesses were proven to be ORSA [9]. Fortunately,
community-acquired ORSA strains are usually susceptible to
oral non-b-lactam agents, such as clindamycin, erythromycin,
trimethoprim-sulfamethoxazole, and fusidic acid.
Trimethoprim-sulfamethoxazole is a cost-effective alterna-
tive weapon against ORSA [10]. On the aspect of neonatal risk,
the American Academy of Pediatrics’ Committee on Drugs
considers trimethoprim-sulfamethoxazole to be compatible
with breastfeeding, but caution should be taken against sulfa-
methoxazole use in infants with known G6PD deficiency [11].
Thus, newborn blood screening for G6PD deficiency, also
known as favism, provides important information for antimi-
crobial selection.
In conclusion, ORSA has emerged as a potential pathogen
in puerperal mastitis, especially for those who do not respond
to empiric b-lactam therapy or in the formation of abscesses.
Puerperal mastitis complicated by abscess formation can be
cured by needle aspiration and adequate antimicrobial therapy.
Culture-proven ORSA infection should be treated with a non-
b-lactam agent based on susceptibility results.References
[1] Barbosa-Cesnik C, Schwartz K, Foxman B. Lactation mastitis. JAMA
2003;289:1609e12.
[2] Reddy P, Qi C, Zembower T, Noskin GA, Bolon M. Emerg Infect Dis.
Postpartum mastitis and community-acquired methicillin-resistant
Staphylococcus aureus 2007;13:298e301.
[3] Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III L,
Wenstrom KD. Williams obstetrics. In: . 22nd ed. New York: McGraw-
Hill; 2005. 704.
[4] Christensen AF, Al-Suliman N, Nielsen KR, Vejborg I, Severinsen N,
Christensen H, et al. Ultrasound-guided drainage of breast abscesses:
results in 151 patients. Br J Radiol 2005;78:186e8.
235I.-W. Lee et al. / Taiwanese Journal of Obstetrics & Gynecology 50 (2011) 233e235[5] World Health Organization. Mastitis: causes and management. WHO/
FCH/CAH/00.13. Geneva: WHO; 2000.
[6] Moreillon P, Que YA, Glauser MP. Staphylococcus aureus. In:
Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Ben-
nett’s principles and practice of infectious diseases. 6th ed. Philadelphia:
Churchill Livingstone; 2005. p. 2321e51.
[7] Bal AM, Gould IM. Antibiotic resistance in Staphylococcus aureus
and its relevance in therapy. Expert Opin Pharmacother 2005;6:
2257e69.
[8] Tillotson GS, Draghi DC, Sahm DF, Tomfohrde KM, Del Fabro T,
Critchley IA. Susceptibility of Staphylococcus aureus isolated from skinand wound infections in the United States 2005-07: laboratory-based
surveillance study. J Antimicrob Chemother 2008;62:109e15.
[9] Stafford I, Hernandez J, Laibl V, Sheffield J, Roberts S, Wendel Jr G.
Community-acquired methicillin-resistant Staphylococcus aureus among
patients with puerperal mastitis requiring hospitalization. Obstet Gynecol
2008;112:533e7.
[10] Pappas G, Athanasoulia AP, Matthaiou DK, Falagas ME. Trimethoprim-
sulfamethoxazole for methicillin-resistant Staphylococcus aureus:
a forgotten alternative? J Chemother 2009;21:115e26.
[11] Briggs GG, Freeman RK, Yaffe SJ. Drugs during pregnancy and lacta-
tion. 7th ed. Baltimore: Lippincott, Williams & Wilkins; 2005. 1635.
